Global Thoracic Surgery Market Growth (Status and Outlook) 2023-2029

Global Thoracic Surgery Market Growth (Status and Outlook) 2023-2029

Thoracic surgery is a procedure to treat medical conditions involving heart and lungs. It includes therapies such as redo heart surgery, aortic dissection for aortic surgery, minimally invasive mitral valve repair and replacement, and endovascular repair of thoracic aortic aneurysms.

LPI (LP Information)' newest research report, the “Thoracic Surgery Industry Forecast” looks at past sales and reviews total world Thoracic Surgery sales in 2022, providing a comprehensive analysis by region and market sector of projected Thoracic Surgery sales for 2023 through 2029. With Thoracic Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thoracic Surgery industry.

This Insight Report provides a comprehensive analysis of the global Thoracic Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thoracic Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thoracic Surgery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thoracic Surgery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thoracic Surgery.

The global Thoracic Surgery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Rise in incidence of cardiac disorders, increase in geriatric population, and lower invasiveness than many traditional surgical procedures are expected to drive the market growth. In addition, advantages of this surgery, such as reduced pain, low blood loss, low risk of infection, and faster healing with shorter hospitalization, supplement the growth. However, dearth of skilled practitioners and stringent regulatory services may hinder the market growth. Growth in use of MRI in cardiac applications, usage of bio-absorbable and self-expandable stents, and potential in emerging nations are expected to present opportunities for market development.

This report presents a comprehensive overview, market shares, and growth opportunities of Thoracic Surgery market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Coronary Artery Bypass Grafting (CABG)
Heart Valve Repair
Transcatheter Heart Valve Replacement (TAVR)
Left Atrial Appendage (LAA) Closure
Thoracic Endovascular Aortic Repair (TEVAR)

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Medtronic
Abbott
AtriCure
BioVentrix
C. R. Bard

Please note: The report will take approximately 2 business days to prepare and deliver.